<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Bard C R Company Newsfeed</title>
<link>http://www.advfn.com/nyse/rss.asp?symbol=BCR</link>
<description>Bard C R Company Newsfeed</description>
<language>en</language>
<pubDate>Wed, 24 Apr 2013 09:04:55 EDT</pubDate>
<lastBuildDate>Wed, 24 Apr 2013 09:04:55 EDT</lastBuildDate>
  
  
 <item>
 <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=57304605&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=57304605&amp;headline=u-s-hot-stock-futures-hot-stocks-to-watch</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Among the companies with shares expected to actively trade in Wednesday's session are Apple Inc. (AAPL), Edwards Lifesciences Corp. (EW) and VMware Inc. (VMW). &#60;/p&#62;
&#60;p&#62; In addition to raising its buyback program and increasing its dividend, Apple Inc. (AAPL) reported a mixed...</description>
 <pubDate>Wed, 24 Apr 2013 09:04:55 EDT</pubDate>
 </item>

 <item>
 <title>High-Grade-Bond Market Absorbs $3.9 Billion of New Deals</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=54698266&amp;headline=high-grade-bond-market-absorbs-3-9-billion-of-new-deals</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=54698266&amp;headline=high-grade-bond-market-absorbs-3-9-billion-of-new-deals</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Patrick McGee &#60;/pre&#62;
&#60;p&#62; The corporate-bond market has faltered somewhat this week amid weak earnings, but conditions were strong enough Thursday to support a combined $3.9 billion of new deals from five high-grade issuers. &#60;/p&#62;
&#60;p&#62; Two jumbo-size deals led the spurt of...</description>
 <pubDate>Thu, 25 Oct 2012 18:32:16 EDT</pubDate>
 </item>

 <item>
 <title>J&amp;J to Stop Selling Surgical Mesh Amid Lawsuits, Concerns -AP</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=52663820&amp;headline=j-j-to-stop-selling-surgical-mesh-amid-lawsuits-concerns-ap</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=52663820&amp;headline=j-j-to-stop-selling-surgical-mesh-amid-lawsuits-concerns-ap</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Johnson &#38;amp; Johnson (JNJ) will, over the next four months, phase out four surgical mesh products used to treat pelvic collapse in women, the Associated Press reported Tuesday. &#60;/p&#62;
&#60;p&#62; The Food and Drug Administration has ordered new studies of the products as it has received...</description>
 <pubDate>Tue, 05 Jun 2012 12:53:24 EDT</pubDate>
 </item>

 <item>
 <title>MARKET SNAPSHOT: U.S. Stock Gains Hinge On Apple, Blue-chip Results</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=52094422&amp;headline=market-snapshot-u-s-stock-gains-hinge-on-apple-blue-chip-results</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=52094422&amp;headline=market-snapshot-u-s-stock-gains-hinge-on-apple-blue-chip-results</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Wallace Witkowski, MarketWatch &#60;/p&#62;
&#60;p&#62; SAN FRANCISCO (MarketWatch) -- Corporate earnings will command the attention of investors in the coming week with about one-third of the S&#38;amp;P 500 and the Dow Jones Industrial Average reporting quarterly results. &#60;/p&#62;
&#60;p&#62; &#34;We're looking...</description>
 <pubDate>Sat, 21 Apr 2012 00:20:37 EDT</pubDate>
 </item>

 <item>
 <title>FDA Orders Post-Market Testing Of Surgical Mesh Amid Safety Concerns</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=50619056&amp;headline=fda-orders-post-market-testing-of-surgical-mesh-amid-safety-concerns</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=50619056&amp;headline=fda-orders-post-market-testing-of-surgical-mesh-amid-safety-concerns</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; WASHINGTON -(Dow Jones)- The Food and Drug Administration is ordering manufacturers of surgical mesh to conduct new studies of the products when used to treat two conditions affecting millions of women, pelvic organ...</description>
 <pubDate>Wed, 04 Jan 2012 16:13:14 EST</pubDate>
 </item>

 <item>
 <title>US Stock Futures: HOT STOCKS TO WATCH</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=50506788&amp;headline=us-stock-futures-hot-stocks-to-watch</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=50506788&amp;headline=us-stock-futures-hot-stocks-to-watch</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Among the companies whose shares are expected to actively trade in Wednesday's session are Oracle Corp. (ORCL), Research In Motion Ltd. (RIMM) and Walgreen Co. (WAG). &#60;/p&#62;
&#60;p&#62; Oracle's second-quarter earnings rose 17% despite a decline in the business-software company's hardware...</description>
 <pubDate>Wed, 21 Dec 2011 09:10:36 EST</pubDate>
 </item>

 <item>
 <title>US Stock Futures Higher On Optimism Ahead Of EU Summit</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49673973&amp;headline=us-stock-futures-higher-on-optimism-ahead-of-eu-summit</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49673973&amp;headline=us-stock-futures-higher-on-optimism-ahead-of-eu-summit</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Nick Godt &#60;/p&#62;
&#60;p&#62; U.S. stock futures pointed to a higher open Wednesday, lifted by hopes that a much-awaited summit of European leaders will present a convincing plan to handle the euro zone's debt crisis. &#60;/p&#62;
&#60;p&#62; Futures on the Dow Jones Industrial Average rose 57 points...</description>
 <pubDate>Wed, 26 Oct 2011 07:57:35 EDT</pubDate>
 </item>

 <item>
 <title>Erste Group Bank To Buy 24.12% Stake In Romania Unit</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49178143&amp;headline=erste-group-bank-to-buy-24-12-stake-in-romania-unit</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49178143&amp;headline=erste-group-bank-to-buy-24-12-stake-in-romania-unit</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; FRANKFURT -(Dow Jones)- Austrian bank Erste Group Bank AG (EBS.VI) said Wednesday it will acquire 24.12% stake in its unit Banca Comerciala Romana S.A. (BCR.YY) for about EUR435 million in cash and stock, after reaching an agreement with four of the five minority shareholders...</description>
 <pubDate>Wed, 14 Sep 2011 14:52:55 EDT</pubDate>
 </item>

 <item>
 <title>FDA Panel Backs Plans For Premarket Studies Of Organ-Prolapse...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49112666&amp;headline=fda-panel-backs-plans-for-premarket-studies-of-organ-prolapse</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=49112666&amp;headline=fda-panel-backs-plans-for-premarket-studies-of-organ-prolapse</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; WASHINGTON -(Dow Jones)- A federal advisory panel Thursday called for more clinical studies and tougher regulation of certain surgical mesh products used to treat pelvic organ prolapse, an often painful condition...</description>
 <pubDate>Thu, 08 Sep 2011 19:18:41 EDT</pubDate>
 </item>

 <item>
 <title>CR Bard Financial Chief Schermerhorn To Retire</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48645201&amp;headline=cr-bard-financial-chief-schermerhorn-to-retire</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48645201&amp;headline=cr-bard-financial-chief-schermerhorn-to-retire</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; Medical-device maker C.R. Bard Inc. (BCR) disclosed a change in a top post Monday, announcing the retirement of its chief financial officer after more than 25 years with the company. &#60;/p&#62;
&#60;p&#62; Todd C. Schermerhorn joined the company in 1985 as a financial...</description>
 <pubDate>Mon, 01 Aug 2011 10:03:11 EDT</pubDate>
 </item>

 <item>
 <title>CR Bard Swings To 2Q Loss On Legal Settlement Charge</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48532297&amp;headline=cr-bard-swings-to-2q-loss-on-legal-settlement-charge</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48532297&amp;headline=cr-bard-swings-to-2q-loss-on-legal-settlement-charge</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Medical-device maker C.R. Bard Inc. (BCR) swung to a second-quarter loss as a previously disclosed $181 million after-tax legal settlement charge masked revenue growth across all product categories. &#60;/p&#62;
&#60;p&#62; Shares slid 7.7% to $104 in after-hours...</description>
 <pubDate>Thu, 21 Jul 2011 17:07:05 EDT</pubDate>
 </item>

 <item>
 <title>CR Bard In Deal To Settle Hernia Suits, Sees $184 Million 2Q...</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48281477&amp;headline=cr-bard-in-deal-to-settle-hernia-suits-sees-184-million-2q</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=48281477&amp;headline=cr-bard-in-deal-to-settle-hernia-suits-sees-184-million-2q</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Medical device maker C.R. Bard Inc. (BCR) has reached a $184 million agreement to settle most of the lawsuits involving faulty hernia repair products it started pulling from the market years ago. &#60;/p&#62;
&#60;p&#62; The company disclosed...</description>
 <pubDate>Thu, 30 Jun 2011 18:26:54 EDT</pubDate>
 </item>

 <item>
 <title>C.R. Bard 1Q Profit Rises 8.8% On Vascular Sales</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=47395659&amp;headline=c-r-bard-1q-profit-rises-8-8-on-vascular-sales</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=47395659&amp;headline=c-r-bard-1q-profit-rises-8-8-on-vascular-sales</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Medical-device maker C.R. Bard Inc.'s (BCR) first-quarter profit rose a better-than-expected 8.8% on revenue growth in its main vascular business. &#60;/p&#62;
&#60;p&#62; A rebound in spending in the health-care sector has driven renewed profits at companies...</description>
 <pubDate>Thu, 21 Apr 2011 17:16:41 EDT</pubDate>
 </item>

 <item>
 <title>Hologic Wins Appellate Ruling In Its Patent Lawsuit</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46634878&amp;headline=hologic-wins-appellate-ruling-in-its-patent-lawsuit</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46634878&amp;headline=hologic-wins-appellate-ruling-in-its-patent-lawsuit</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Hologic Inc. (HOLX) said an appellate court has ruled in its favor in relation to a suit it had filed in early 2008 against SenoRx Inc. alleging infringement on some Hologic brachytherapy patent claims. &#60;/p&#62;
&#60;p&#62; The maker of diagnostics, medical-imaging...</description>
 <pubDate>Fri, 25 Feb 2011 15:05:05 EST</pubDate>
 </item>

 <item>
 <title>CR Bard Sees 1Q EPS Of $1.43 To $1.47</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46243251&amp;headline=cr-bard-sees-1q-eps-of-1-43-to-1-47</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46243251&amp;headline=cr-bard-sees-1q-eps-of-1-43-to-1-47</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; C.R. Bard Inc. (BCR) said Monday it expects to post first-quarter earnings in a range of $1.43 to $1.47 per share, which brackets Wall Street expectations. &#60;/p&#62;
&#60;p&#62; The per-share earnings view excludes any items that could affect...</description>
 <pubDate>Mon, 31 Jan 2011 18:23:03 EST</pubDate>
 </item>

 <item>
 <title>CR Bard 4Q Profit Climbs 29%, Helped By Better Revenue</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46241301&amp;headline=cr-bard-4q-profit-climbs-29-helped-by-better-revenue</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=46241301&amp;headline=cr-bard-4q-profit-climbs-29-helped-by-better-revenue</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; C. R. Bard Inc.'s (BCR) fourth-quarter earnings climbed 29%, topping the company's own estimates, as sales and margins improved. &#60;/p&#62;
&#60;p&#62; The medical-products maker, which produces vascular, urology and oncology devices, has seen revenue rise...</description>
 <pubDate>Mon, 31 Jan 2011 16:55:19 EST</pubDate>
 </item>

 <item>
 <title>CR Bard Voluntarily Recalls XenMatrix Surgical Graft Product</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=45968980&amp;headline=cr-bard-voluntarily-recalls-xenmatrix-surgical-graft-product</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=45968980&amp;headline=cr-bard-voluntarily-recalls-xenmatrix-surgical-graft-product</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; C.R. Bard Inc. (BCR) disclosed Tuesday that its Davol Inc. subsidiary has voluntarily recalled a surgical-graft product called XenMatrix that is used in hernia and abdominal wall repair. &#60;/p&#62;
&#60;p&#62; The medical-device maker said its...</description>
 <pubDate>Tue, 11 Jan 2011 10:04:22 EST</pubDate>
 </item>

 <item>
 <title>CR Bard To Cut Jobs In Plan To Improve Cost Structure</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=45634822&amp;headline=cr-bard-to-cut-jobs-in-plan-to-improve-cost-structure</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=45634822&amp;headline=cr-bard-to-cut-jobs-in-plan-to-improve-cost-structure</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Jon Kamp Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; Medical-device maker C.R. Bard Inc. (BCR) said Monday it has a new cost-curbing and restructuring plan that will include an undefined number of staffing cuts. &#60;/p&#62;
&#60;p&#62; &#34;The plan includes the realignment of certain manufacturing...</description>
 <pubDate>Mon, 13 Dec 2010 17:39:54 EST</pubDate>
 </item>

 <item>
 <title>C.R. Bard 3Q Net Down 1.5% On Charges; Sales Fall Short</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=44889050&amp;headline=c-r-bard-3q-net-down-1-5-on-charges-sales-fall-short</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=44889050&amp;headline=c-r-bard-3q-net-down-1-5-on-charges-sales-fall-short</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; C.R. Bard Inc.'s (BCR) third-quarter profit fell 1.5% on acquisition and other charges as the medical-products maker reported revenue below analysts' expectations. &#60;/p&#62;
&#60;p&#62; The company--which makes vascular, urology and oncology devices--had...</description>
 <pubDate>Thu, 21 Oct 2010 17:07:47 EDT</pubDate>
 </item>

 <item>
 <title>FDA Warns About Long-Term Problems With Blood-Clot Device</title>
 <link>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=43939720&amp;headline=fda-warns-about-long-term-problems-with-blood-clot-device</link>
 <guid>http://www.advfn.com/nyse/StockNews.asp?stocknews=BCR&amp;article=43939720&amp;headline=fda-warns-about-long-term-problems-with-blood-clot-device</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; By Jennifer Corbett Dooren &#60;/p&#62;
&#60;p&#62; Of DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; WASHINGTON -(Dow Jones)- The Food and Drug Administration warned Monday that certain devices used to keep blood clots from traveling to the lungs could fracture and migrate to other parts of the body. &#60;/p&#62;
&#60;p&#62;...</description>
 <pubDate>Mon, 09 Aug 2010 15:22:30 EDT</pubDate>
 </item>

</channel>
</rss>